Australia's leading research commercialisation company

We commercialise UQ research to create change and deliver solutions for a better world.

Established in 1984, we are Australia’s leading technology transfer company.

Our innovation portfolio includes Australia’s first blockbuster vaccine Gardasil®, the internationally acclaimed Triple P-Positive Parenting Program, UQ’s superconductor technology, which is used in most of the world’s Magnetic Resonance Imaging (MRI) machines, and, in 2015 our spin-out Spinifex Pharmaceuticals secured Australia’s largest ever biotechnology acquisition.

Our commercialisation impact makes UQ Australia’s leading university for licence income and value of equity held in spin-out companies*.

*National Survey of Research Commercialisation, Department of Industry, Innovation and Science, 2016.

Our Vision

Delivering solutions for a better world.

Our Mission

Commercialising UQ research to create change.

Our Values


Respectful of the views of others and open to change.

Act with integrity

Manage conflict of interest, accountable and professional.


Value our people, consultative and communicate effectively.


Honest, reliable and empowered.

Commercial excellence

Financially astute with timely and disciplined decision-making.

Available technologies

We have a suite of available technologies and discoveries to give your business an innovative edge.

Discover more